Other OTC - Delayed Quote USD

Kane Biotech Inc. (KNBIF)

0.0898 0.0000 (0.00%)
At close: April 12 at 12:50 PM EDT
Key Events
Loading Chart for KNBIF
DELL
  • Previous Close 0.0898
  • Open 0.0940
  • Bid --
  • Ask --
  • Day's Range 0.0898 - 0.0898
  • 52 Week Range 0.0420 - 0.1228
  • Volume 84,000
  • Avg. Volume 6,039
  • Market Cap (intraday) 12.066M
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date May 23, 2024 - May 27, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

kanebiotech.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KNBIF

Performance Overview: KNBIF

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

KNBIF
46.73%
S&P/TSX Composite index
4.82%

1-Year Return

KNBIF
0.06%
S&P/TSX Composite index
7.48%

3-Year Return

KNBIF
40.88%
S&P/TSX Composite index
15.01%

5-Year Return

KNBIF
70.82%
S&P/TSX Composite index
32.54%

Compare To: KNBIF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KNBIF

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    12.02M

  • Enterprise Value

    18.22M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    105.05

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    122.31

  • Enterprise Value/EBITDA

    -5.86

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -37.06%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    148.98k

  • Net Income Avi to Common (ttm)

    -4.56M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    749.25k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.45M

Company Insights: KNBIF

People Also Watch